Related Experiment Video
Updated: Jul 7, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Single-molecule observations of topotecan-mediated TopIB activity at a unique DNA sequence
Daniel A Koster1, Fabian Czerwinski, Ludovic Halby
1Kavli Institute of Nanoscience, Faculty of Applied Sciences, Delft University of Technology, Lorentzweg 1, 2628 CJ Delft, The Netherlands.
Abstract:
The rate of DNA supercoil removal by human topoisomerase IB (TopIB) is slowed down by the presence of the camptothecin class of antitumor drugs. By preventing religation, these drugs also prolong the lifetime of the covalent TopIB-DNA complex. Here, we use magnetic tweezers to measure the rate of supercoil removal by drug-bound TopIB at a single DNA sequence in real time. This is accomplished by covalently linking camptothecins to a triple helix-forming oligonucleotide that binds at one location on the DNA molecule monitored. Surprisingly, we find that the DNA dynamics with the TopIB-drug interaction restricted to a single DNA sequence are indistinguishable from the dynamics observed when the TopIB-drug interaction takes place at multiple sites. Specifically, the DNA sequence does not affect the instantaneous supercoil removal rate or the degree to which camptothecins increase the lifetime of the covalent complex. Our data suggest that sequence-dependent dynamics need not to be taken into account in efforts to develop novel camptothecins.
Insights
Camptothecin drugs slow DNA supercoil removal by human topoisomerase IB (TopIB). This study shows DNA sequence does not affect TopIB-drug interactions, simplifying future drug development.
Area of Science:
- Molecular Biology
- Biophysics
- Pharmacology
Background:
- Human topoisomerase IB (TopIB) is crucial for managing DNA topology.
- Camptothecin drugs inhibit TopIB by trapping it in a covalent complex with DNA.
- Understanding TopIB-drug interactions is key for developing new anticancer therapies.
Purpose of the Study:
- To investigate the impact of DNA sequence on the dynamics of TopIB inhibition by camptothecins.
- To quantify the effect of camptothecins on the rate of supercoil removal by TopIB at a specific DNA site.
- To determine if sequence-specific interactions influence the lifetime of the TopIB-drug-DNA complex.
Main Methods:
- Utilized single-molecule magnetic tweezers to monitor DNA supercoil removal in real time.
- Covalently attached camptothecins to a triple helix-forming oligonucleotide for site-specific drug interaction.
- Measured the rate of supercoil removal and covalent complex lifetime under controlled conditions.
Main Results:
- The rate of DNA supercoil removal by drug-bound TopIB was independent of the specific DNA sequence.
- Restricting camptothecin interaction to a single DNA site yielded dynamics indistinguishable from multi-site interactions.
- Camptothecins' effect on the covalent complex lifetime was not sequence-dependent.
Conclusions:
- DNA sequence does not influence the dynamics of TopIB inhibition by camptothecins.
- The findings simplify the development of novel camptothecin-based anticancer drugs by removing sequence-dependency considerations.
- This research provides a foundation for rational drug design targeting TopIB.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

